Cargando…

Construction and experimental validation of a B cell-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer

Background: B cells are essential components of tumor microenvironment and exert important functions in anti-tumor immune response. However, the prognosis value of B cell-related genes in bladder cancer (BLCA) remains obscure. Materials and Methods: The infiltrating levels of B cells were measured v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ranran, Zhou, Jiawei, Muhuitijiang, Bahaerguli, Zeng, Xiangbo, Tan, Wanlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333061/ https://www.ncbi.nlm.nih.gov/pubmed/37379131 http://dx.doi.org/10.18632/aging.204753

Ejemplares similares

An artificial neural network model to diagnose non-obstructive azoospermia based on RNA-binding protein-related genes
por: Peng, Fan, et al.
Publicado: (2023)

An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2022)

Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer
por: Li, Canxuan, et al.
Publicado: (2023)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Construction and experimental validation of an acetylation-related gene signature to evaluate the recurrence and immunotherapeutic response in early-stage lung adenocarcinoma
por: Wang, Haiqiang, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer
por: Shen, Chong, et al.
Publicado: (2023)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation
por: Liu, Zijian, et al.
Publicado: (2022)

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq
por: Zhou, Ranran, et al.
Publicado: (2021)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Molecular characterization of ferroptosis in soft tissue sarcoma constructs a prognostic and immunotherapeutic signature through experimental and bioinformatics analyses
por: Yang, Zhi-Qiang, et al.
Publicado: (2023)

Immunotherapeutic strategies for bladder cancer
por: Chevalier, Mathieu F, et al.
Publicado: (2014)

Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2021)

Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis
por: Liao, Yong, et al.
Publicado: (2022)

Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer
por: Li, Xuanzong, et al.
Publicado: (2022)

Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs
por: Guo, Youwei, et al.
Publicado: (2023)

Construction and validation of a robust ferroptosis-associated gene signature predictive of prognosis in lung adenocarcinoma
por: Zhou, Mi, et al.
Publicado: (2022)

A circadian rhythm-related gene signature associated with tumor immunity, cisplatin efficacy, and prognosis in bladder cancer
por: Zhou, Ranran, et al.
Publicado: (2021)

Identification of autophagy‐related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2021)

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
por: Wang, Jia‐Bin, et al.
Publicado: (2023)

Construction and validation of an eight-gene signature with great prognostic value in bladder cancer
por: Yan, Xin, et al.
Publicado: (2020)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma
por: Li, Chang, et al.
Publicado: (2020)

Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
por: Yang, Jinpo, et al.
Publicado: (2022)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

ExoHCR: a sensitive assay to profile PD-L1 level on tumor exosomes for immunotherapeutic prognosis
por: Hu, Lujun, et al.
Publicado: (2020)

Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy
por: Ma, Jianli, et al.
Publicado: (2022)

Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer
por: Song, Li, et al.
Publicado: (2023)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
por: Jiang, Wen, et al.
Publicado: (2020)

Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer
por: Cao, Lichao, et al.
Publicado: (2022)

Construction of an Immunophenoscore-Related Signature for Evaluating Prognosis and Immunotherapy Sensitivity in Ovarian Cancer
por: Jiang, Haonan, et al.
Publicado: (2023)

Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer
por: Wang, Dengchuan, et al.
Publicado: (2023)

Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancer
por: Wu, Li-Hong, et al.
Publicado: (2023)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4onoo6fka7ecgrq3gjor5oikt